See which services passed our medical vetting process. Share on Pinterest Mounjaro (tirzepatide), the injectable medication that’s approved for diabetes by the Food and Drug Administration (FDA ...

Citi analyst Daniel Grosslight says Hims & Hers traded up 10% yesterday after Bloomberg noted the company is now offering branded ...

Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide.

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

The Outsourcing Facilities Association (OFA), an organization representing bulk compounders ... insulinotropic polypeptide receptor agonist tirzepatide. Just last week, district court judge ...

The clinical benefits of tirzepatide in patients with HFpEF and obesity were consistent regardless of kidney function. The effect of tirzepatide on kidney function depends on how CKD is defined ...

But which medication is right for you? Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially ...

Previous studies have shown improved kidney function with other drugs in the same class but this trial is the first to assess tirzepatide's impact on kidney and cardiovascular outcomes in people ...

19% achieved 7% reduction in weight (p<0.1). Low dose bremelanotide arm stopped weight regain seen post tirzepatide treatment. Palatin Technologies, Inc. "Although the study was not designed to ...